Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

1,471 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma trial results

Recruiting

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

NCT05303519

Conditions
Astrocytoma, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, +22 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Recruiting

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

NCT06805305

Conditions
Astrocytoma, Glioblastoma, Glioblastoma (GBM), +8 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • HOAG Newport Beach, California, United States
  • UCSF San Francisco, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study of DEG6498 in Participants With Solid Tumors

NCT07244835

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +70 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

NCT06333899

Conditions
Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +24 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 18 locations
View Trial Details
Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

NCT06914128

Conditions
Astrocytoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • UCLA Health Bowyer Oncology Center Los Angeles, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights - Neurology San Francisco, California, United States
View all 60 locations
View Trial Details

Related conditions